Biomarkers in Cardiovascular Endocrinology: The Endocrine Society’s 2009 Corporate Liaison Board Forum
|
Tuesday, June 16, 2009 Contacts: Arlyn G. Riskind Director, Media Relations Phone: (301) 941-0240; Cell: (202) 431-9495 ariskind@endo-society.org Aaron Lohr Manager, Media Relations Phone: (240) 482-1380 Email: alohr@endo-society.org Washington, DC— The Endocrine Society’s Corporate Liaison Board (CLB) will host its annual forum on Wednesday June 10, as part of ENDO 09, the Society’s 91th Annual Meeting. The 2009 topic for the forum is “Biomarkers in Cardiovascular Endocrinology in Clinical Trials & Drug Development.”
# # # Founded in 1916, The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 14,000 scientists, physicians, educators, nurses and students in more than 80 countries. Together, these members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Md. To learn more about the Society, and the field of endocrinology, visit our web site at www.endo-society.org. |